Dr. James Wharton, MD

NPI: 1386619203
Total Payments
$1.2M
2024 Payments
$119,379
Companies
40
Transactions
1,647
Medicare Patients
14,245
Medicare Billing
$3.5M

Payment Breakdown by Category

Other$988,273 (81.7%)
Travel$159,678 (13.2%)
Consulting$30,870 (2.6%)
Food & Beverage$30,832 (2.5%)
Education$585.75 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $566,273 192 46.8%
Honoraria $422,000 105 34.9%
Travel and Lodging $159,678 291 13.2%
Consulting Fee $30,870 12 2.6%
Food and Beverage $30,832 1,036 2.5%
Education $585.75 11 0.0%

Top Paying Companies

Company Total Records Latest Year
SUN PHARMACEUTICAL INDUSTRIES INC. $811,595 689 $0 (2024)
Amgen Inc. $204,362 209 $0 (2024)
Celgene Corporation $149,303 147 $0 (2019)
Incyte Corporation $27,254 31 $0 (2024)
ABBVIE INC. $9,570 205 $0 (2024)
Janssen Biotech, Inc. $1,031 58 $0 (2024)
Almirall LLC $996.47 12 $0 (2024)
UCB, Inc. $837.27 35 $0 (2024)
Novartis Pharmaceuticals Corporation $829.83 46 $0 (2024)
Lilly USA, LLC $738.03 46 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $119,379 199 SUN PHARMACEUTICAL INDUSTRIES INC. ($99,671)
2023 $162,622 244 Sun Pharmaceutical Industries Inc. ($97,502)
2022 $200,790 244 Sun Pharmaceutical Industries Inc. ($134,648)
2021 $206,273 240 SUN PHARMACEUTICAL INDUSTRIES INC. ($154,481)
2020 $199,598 226 Sun Pharmaceutical Industries Inc. ($163,121)
2019 $205,140 231 Sun Pharmaceutical Industries Inc. ($161,986)
2018 $71,383 144 Celgene Corporation ($63,785)
2017 $45,054 119 Celgene Corporation ($43,431)

All Payment Transactions

1,647 individual payment records from CMS Open Payments — Page 1 of 66

Date Company Product Nature Form Amount Type
12/16/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $29.06 General
Category: Immunology
12/11/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $22.90 General
Category: INFLAMMATION AND IMMUNOLOGY
12/09/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $38.08 General
Category: Dermatology
12/06/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $20.78 General
Category: Immunology
12/05/2024 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $15.46 General
12/04/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,625.00 General
Category: Dermatology
12/04/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Travel and Lodging In-kind items and services $549.00 General
Category: Dermatology
12/04/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Travel and Lodging In-kind items and services $219.98 General
Category: Dermatology
12/04/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Travel and Lodging In-kind items and services $199.98 General
Category: Dermatology
12/04/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Travel and Lodging In-kind items and services $148.55 General
Category: Dermatology
12/04/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $125.00 General
Category: Dermatology
12/02/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,375.00 General
Category: Dermatology
12/02/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $40.82 General
Category: Dermatology
11/27/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $8.33 General
Category: Immunology
11/25/2024 Amgen Inc. Otezla (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,600.00 General
Category: Inflammation
11/22/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Odomzo (Drug), BLU-U Food and Beverage In-kind items and services $18.79 General
Category: Oncology
11/22/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $15.13 General
Category: IMMUNOLOGY
11/22/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $7.05 General
Category: Dermatology
11/20/2024 UCB, Inc. Bimzelx (Biological) Food and Beverage In-kind items and services $40.47 General
Category: Immunology
11/19/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $18.43 General
Category: IMMUNOLOGY
11/19/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $13.61 General
Category: IMMUNOLOGY
11/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $25.80 General
Category: IMMUNOLOGY
11/14/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $8.50 General
Category: Inflammation
11/13/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $26.98 General
Category: Immunology
11/11/2024 SUN PHARMACEUTICAL INDUSTRIES INC. ILUMYA (Biological) Food and Beverage In-kind items and services $24.91 General
Category: Dermatology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 30 3,315 10,475 $2.6M $924,510
2022 33 3,542 10,761 $2.3M $835,674
2021 32 3,951 11,611 $3.7M $936,250
2020 31 3,437 10,383 $2.2M $807,618
Total Patients
14,245
Total Services
43,230
Medicare Billing
$3.5M
Procedure Codes
126

All Medicare Procedures & Services

126 procedure records from CMS Medicare Utilization — Page 1 of 6

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J3245 Injection, tildrakizumab, 1 mg Office 2023 21 4,701 $1.3M $494,378 39.5%
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks Office 2023 250 316 $396,309 $137,764 34.8%
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks Office 2023 127 235 $178,164 $69,869 39.2%
88305 Pathology examination of tissue using a microscope, intermediate complexity Office 2023 489 818 $107,772 $38,041 35.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 480 583 $98,834 $32,588 33.0%
11102 Biopsy of related skin growth, first growth Office 2023 271 322 $59,867 $18,533 31.0%
17000 Destruction of precancer skin growth, 1 growth Office 2023 396 521 $64,618 $16,668 25.8%
17110 Destruction of skin growth, 1-14 growths Office 2023 197 220 $45,676 $15,299 33.5%
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm Office 2023 98 104 $60,947 $12,189 20.0%
17313 Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks Office 2023 25 26 $30,593 $11,531 37.7%
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm Office 2023 58 59 $33,147 $8,632 26.0%
15260 Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less Office 2023 11 11 $20,520 $8,044 39.2%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 312 1,812 $22,052 $7,547 34.2%
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm Office 2023 71 82 $22,381 $7,186 32.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 76 98 $24,604 $7,142 29.0%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 39 49 $15,268 $5,276 34.6%
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm Office 2023 32 40 $13,205 $4,048 30.7%
11103 Biopsy of related skin growth, each additional growth Office 2023 62 110 $10,184 $3,967 38.9%
12051 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less Office 2023 37 37 $19,423 $3,952 20.3%
12053 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 5.1-7.5 cm Office 2023 20 21 $14,173 $3,046 21.5%
12042 Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm Office 2023 25 25 $14,356 $3,042 21.2%
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm Office 2023 15 15 $13,140 $3,027 23.0%
17250 Application of chemical to stop tissue regrowth in wound Office 2023 15 49 $7,835 $2,883 36.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 39 39 $8,204 $2,626 32.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 72 76 $8,002 $2,543 31.8%

About Dr. James Wharton, MD

Dr. James Wharton, MD is a Dermatopathology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386619203.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Wharton, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $119,379 received in 2024. These payments were reported across 1,647 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($566,273).

As a Medicare-enrolled provider, Wharton has provided services to 14,245 Medicare beneficiaries, totaling 43,230 services with total Medicare billing of $3.5M. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.

Practice Information

  • Specialty Dermatopathology
  • Other Specialties Dermatopathology, Dermatology
  • Location Lexington, KY
  • Active Since 02/22/2006
  • Last Updated 10/28/2025
  • Taxonomy Code 207ND0900X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1386619203

Products in Payments

  • ILUMYA (Biological) $656,373
  • Otezla (Drug) $344,436
  • Ilumya (Biological) $154,422
  • OPZELURA (Drug) $22,278
  • SKYRIZI (Biological) $1,202
  • Klisyri (Drug) $938.16
  • Humira (Biological) $751.64
  • TALTZ (Drug) $718.76
  • Cimzia (Drug) $665.59
  • RINVOQ (Biological) $653.79
  • COSENTYX (Biological) $616.21
  • TREMFYA (Drug) $584.01
  • Ameluz (Drug) $532.98
  • Sotyktu (Drug) $531.68
  • DUPIXENT (Biological) $416.03
  • EUCRISA (Drug) $319.73
  • HUMIRA (Biological) $302.35
  • REMICADE (Biological) $264.93
  • Enbrel (Biological) $220.44
  • Bimzelx (Biological) $171.68

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatopathology Doctors in Lexington